Glympse Bio

OverviewSuggest Edit

Glympse Bio operates as a biotechnology company. The Company develops a proprietary, whole-genome database of enzymes and sensors capable of targeting all clinically-relevant proteases. 

TypePrivate
Founded2015
HQCambridge, MA, US
Websiteglympsebio.com

Latest Updates

Employees (est.) (Aug 2022)35(-7%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Glympse Bio

Caroline J. Loew

Caroline J. Loew

Director, President & Chief Executive Officer
Wendy Winckler

Wendy Winckler

Chief Scientific Officer
Jessica Atkinson

Jessica Atkinson

Senior Vice President, Business Development
Dhaval Gosalia

Dhaval Gosalia

Vice President, Strategy and Operations
Gabe A. Kwong

Gabe A. Kwong

Co-Founder
Show more

Glympse Bio Office Locations

Glympse Bio has an office in Cambridge
Cambridge, MA, US (HQ)
35 Cambridge Park Dr Suite 350
Show all (1)

Glympse Bio Financials and Metrics

Summary Metrics

Founding Date

2015

Glympse Bio total Funding

$68.7 m

Glympse Bio latest funding size

$46.7 m

Time since last funding

2 years ago

Glympse Bio investors

Glympse Bio's latest funding round in July 2020 was reported to be $46.7 m. In total, Glympse Bio has raised $68.7 m
Show all financial metrics

Glympse Bio Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

Glympse Bio Online and Social Media Presence

Embed Graph

Glympse Bio News and Updates

Glympse Bio Appoints Matthew T. Navarro, J.D., as Chief Financial Officer

CAMBRIDGE, Mass., July 20, 2021 /PRNewswire/ -- Glympse Bio, a biotechnology company evolving the way diseases are understood, tracked, and treated, today announced the appointment of Matthew T. Navarro, J.D., to the newly-created role of Chief Financial Officer. Mr. Navarro plays a...

Glympse Bio Announces $46.7 Million Series B Financing

CAMBRIDGE, Mass., July 15, 2020 /PRNewswire/ -- Glympse Bio (Glympse), a biotechnology company advancing the way diseases are understood, tracked, and treated, has closed an oversubscribed $46.7 million Series B financing. The proceeds from the financing will support continued development...

Glympse Bio Frequently Asked Questions

  • When was Glympse Bio founded?

    Glympse Bio was founded in 2015.

  • Who are Glympse Bio key executives?

    Glympse Bio's key executives are Caroline J. Loew, Wendy Winckler and Jessica Atkinson.

  • How many employees does Glympse Bio have?

    Glympse Bio has 35 employees.

  • Who are Glympse Bio competitors?

    Competitors of Glympse Bio include X-Therma, Ceramisphere and Ademtech.

  • Where is Glympse Bio headquarters?

    Glympse Bio headquarters is located at 35 Cambridge Park Dr Suite 350, Cambridge.

  • Where are Glympse Bio offices?

    Glympse Bio has an office in Cambridge.

  • How many offices does Glympse Bio have?

    Glympse Bio has 1 office.